A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: Results of the long-term ASP1941 safety evaluation in patients with type 2 diabetes with renal impairment (LANTERN) study - Kashiwagi, A; Takahashi, H; Ishikawa, H (Diabetes Obes Metab, 2015)
et al.